Takamasa Nakasuka

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

Johannes Brägelmann, Carina Lorenz, Sven Borchmann et al. · Nature Communications · 2021 · 70 citations · Full text

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani et al. · Cancer Science · 2021 · 47 citations · Full text

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka et al. · CHEST Journal · 2019 · 36 citations

Cancer Epidemiology, Medicine, Epidemiology Of Cancer +9

CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in <i>Egfr</i> -Mutant Lung Cancer

Kazuya Nishii, Kadoaki Ohashi, Shuta Tomida et al. · Cancer Immunology Research · 2022 · 22 citations

Multiple Mucosa-associated Lymphoid Tissue Lymphoma of the Trachea

Daisuke Minami, Chihiro Ando, Ken Sato et al. · Internal Medicine · 2017 · 17 citations · Full text

Asthma, Primary Pulmonary Carcinoma, Multiple Nodules +14